dc.contributor.advisor | Hutt, Peter Barton | en_US |
dc.contributor.author | Choi, Adela M. | en_US |
dc.date.accessioned | 2012-06-07T05:03:56Z | |
dc.date.issued | 2001 | en_US |
dc.identifier.citation | Biotechnology and the Labeling Dilemma (2001 Third Year Paper) | en |
dc.identifier.uri | http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846803 | |
dc.description.abstract | This paper will examine the arguments and motivations underlying the FDA stand against mandatory labeling of genetically engineered foods and ingredients. Part I of the paper will describe FDA’s current regulatory policy towards genetically engineered foods. Part II will advance the theoretical basis for the labeling argument. Part III will explore the FDA and industry’s arguments against labeling. Part IV will evaluate those FDA and industry responses. Part V will examine how predictions about public risk perceptions may have shaped the FDA’s labeling stance. Finally, Part VI will examine the realities facing the government and industry that may affect the direction of labeling policy in the future. | en |
dc.language.iso | en_US | en |
dash.license | LAA | en_US |
dc.subject | Food and Drug Law | en |
dc.subject | biotechnology | en |
dc.subject | genetically engineered food | en |
dc.subject | gm food | en |
dc.subject | FDA | en |
dc.subject | labeling | en |
dc.title | Biotechnology and the Labeling Dilemma | en |
dc.type | Paper (for course/seminar/workshop) | en_US |
dc.date.available | 2012-06-07T05:03:56Z | |
dash.authorsordered | false | |